We are live on ! Find out more
N

Natixis Portfolio holdings

AUM $24.8B
1-Year Est. Return 35.22%
 

Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.

This Fund
S&P 500
This Quarter Est. Return
-1.92%
1 Year Est. Return
+35.22%
3 Year Est. Return
+126.04%
5 Year Est. Return
+138.3%
10 Year Est. Return
+549.16%
AUM
$28.7B
AUM Growth
-$598M
Cap. Flow
+$573M
Cap. Flow %
2%
Top 10 Hldgs %
29.98%
Holding
1,407
New
197
Increased
440
Reduced
453
Closed
265

Sector Composition

Rank Sector Weight
1 Technology 20.79%
2 Miscellaneous 16.69%
3 Consumer Discretionary 12.15%
4 Healthcare 10.69%
5 Financials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERIE icon
801
Erie Indemnity
ERIE
$12.7B
$1.46M 0.01%
8,305
-72
-0.9% -$12.9K
WST icon
802
West Pharmaceutical
WST
$23.7B
$1.42M 0.01%
3,464
-12,514
-78% -$4.9M
PRFZ icon
803
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.76B
$1.41M ﹤0.01%
38,580
+8,175
+27% +$297K
SGI
804
Somnigroup International
SGI
$14.4B
$1.4M ﹤0.01%
50,200
+5,900
+13% +$217K
ALB icon
805
Albemarle
ALB
$14.9B
$1.4M ﹤0.01%
6,321
-33,785
-84% -$7.14M
SHLS icon
806
Shoals Technologies Group
SHLS
$1.19B
$1.39M ﹤0.01%
+81,521
New +$1.41M
SNDR icon
807
Schneider National
SNDR
$5.92B
$1.39M ﹤0.01%
+54,300
New +$1.41M
FLS icon
808
Flowserve
FLS
$9.56B
$1.38M ﹤0.01%
+38,501
New +$1.26M
VRTX icon
809
Vertex Pharmaceuticals
VRTX
$132B
$1.38M ﹤0.01%
5,296
-15,127
-74% -$3.59M
CASH icon
810
Pathward Financial
CASH
$1.64B
$1.37M ﹤0.01%
25,000
+11,600
+87% +$659K
OZK icon
811
Bank OZK
OZK
$5.31B
$1.37M ﹤0.01%
32,000
-20,000
-38% -$932K
NTRS icon
812
Northern Trust
NTRS
$33.8B
$1.36M ﹤0.01%
11,718
-18,393
-61% -$2.18M
PENG
813
Penguin Solutions Inc
PENG
$2.62B
$1.36M ﹤0.01%
52,512
NTRA icon
814
Natera
NTRA
$47.6B
$1.35M ﹤0.01%
+33,300
New +$2M
HESM icon
815
Hess Midstream
HESM
$5.21B
$1.35M ﹤0.01%
+45,000
New +$1.36M
OLLI icon
816
Ollie's Bargain Outlet
OLLI
$4.3B
$1.35M ﹤0.01%
31,407
-23,467
-43% -$1.05M
PHDG icon
817
Invesco S&P 500 Downside Hedged ETF
PHDG
$61.4M
$1.31M ﹤0.01%
36,309
+5,280
+17% +$194K
SBAC icon
818
SBA Communications
SBAC
$19.8B
$1.31M ﹤0.01%
3,811
-57,794
-94% -$18.7M
VMI icon
819
Valmont Industries
VMI
$9.28B
$1.28M ﹤0.01%
5,365
-1,247
-19% -$284K
CACI icon
820
CACI
CACI
$13.4B
$1.28M ﹤0.01%
4,246
-33
-0.8% -$9.11K
AES icon
821
AES
AES
$10.6B
$1.27M ﹤0.01%
49,379
-102,399
-67% -$2.31M
VRNT
822
DELISTED
Verint Systems
VRNT
$1.26M ﹤0.01%
24,424
+157
+0.6% +$8.07K
EVRG icon
823
Evergy
EVRG
$18.7B
$1.26M ﹤0.01%
18,414
-21,556
-54% -$1.39M
ITRI icon
824
Itron
ITRI
$4.14B
$1.26M ﹤0.01%
23,838
-4,867
-17% -$272K
FLO icon
825
Flowers Foods
FLO
$1.32B
$1.25M ﹤0.01%
+48,700
New +$1.33M

Similar funds

Natixis's Q1 2022 Portfolio in Review

As of Q1 2022, Natixis held 1,407 positions worth $28.7B, down 2% from $29.3B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Natixis's Q1 2022 filing shows 197 new, 440 increased, 453 reduced and 265 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,057,000 shares worth $232M. The largest sale was Apple, an estimated $811M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

  • Natixis's largest Q1 2022 buy was State Street Financial Select Sector SPDR ETF: 6,057,000 shares worth $232M.
  • Natixis added most to ExxonMobil in Q1 2022, an estimated $339M increase.
  • Natixis's biggest Q1 2022 reduction was Apple, cutting an estimated $811M.
  • Natixis fully exited Xilinx Inc in Q1 2022, selling an estimated $341M.
  • Natixis's ten largest holdings make up 30% of its $28.7B portfolio in Q1 2022.
  • Natixis opened 197 new positions and closed 265 in Q1 2022.
  • Natixis's portfolio value fell 2% quarter-over-quarter to $28.7B.

Based on Natixis's 13F filing for Q1 2022, filed 13 May 2022.